Amarin Corp Plc (AMRN)

[Whalatane]

Hamoa ...suggest you read HDG's recent response to my questions

Quote:
Any insight into API ( EPA ) supply agreements . Nisshu ? has a supply agreement with AMRN ( from memory ) but I believe Nisshu has declared they have excess capacity

Amarin partner (among others) is Nisshin Pharma ... Nippon Suisan has a new fish-oil EPA plant with 420 tons/year in capacity and is currently operating at 50% utilization.

Quote:
My understanding is that Hikma/ Dr R will have 6 mths exclusivity once they launch ...but would expect Apotex to quickly follow

Hikma was the first filler, has 180-day exclusivity ... if they launch on or before November 20, 2020 (78 days from CAFC order ... "forfeit deadline"). I am sure they will in some form to keep the exclusivity.

So if I am reading this correctly ...Hikma will have access to EPA thru Nippon- Suisan since they have available capacity to produce it .
Hikma will launch in some fashion before Nov 20 2020 to maintain their exclusivity .

There is no way IMHO that Hikma will wait 2 yrs .
Kiwi